These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11966752)

  • 1. Does normalization of prolactin levels result in weight loss in patients with prolactin secreting pituitary adenomas?
    Yermus R; Ezzat S
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):562. PubMed ID: 11966752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Don't miss prolactinoma! On the importance of measuring prolactin and how it is done].
    Lindstedt G; Lundberg PA; Jakobsson KE; Tägnfors U; Janson PO
    Lakartidningen; 2000 Jan; 97(4):333-6. PubMed ID: 10684228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactinoma and body weight: a retrospective study.
    Creemers LB; Zelissen PM; van 't Verlaat JW; Koppeschaar HP
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):392-6. PubMed ID: 1957557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and results for treatment of prolactin and growth hormone secreting pituitary tumors].
    Wiesner TD; Trantakis C; Meixensberger J; Koch CA; Zimmer C; Paschke R
    Med Klin (Munich); 2005 Apr; 100(4):173-9. PubMed ID: 15834525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative analysis of surgical and medical treatment of macroprolactinoma of different localization].
    Astaf'eva LI; Kadashev BA; Dedov II; Kalinin PL; Kutin MA; Shkaburo AN; Fomichev DV; Tenedieva VD; Tropinskaia OF
    Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(4):3-9; discussion 9. PubMed ID: 22379847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some issues in the diagnosis and treatment of hyperprolactinemia].
    Jin ZM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apropos of the article by Ph. Otten et al.: "Prolactin-secreting pituitary adenomas"].
    Guy G; Bigorgne JC
    Neurochirurgie; 1996; 42(2):123. PubMed ID: 8952906
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant prolactinoma.
    Berezin M; Gutman I; Tadmor R; Horowitz A; Findler G
    Acta Endocrinol (Copenh); 1992 Nov; 127(5):476-80. PubMed ID: 1471460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower prolactin levels during cabergoline treatment are associated to tumor shrinkage in prolactin secreting pituitary adenoma.
    Lombardi M; Lupi I; Cosottini M; Rossi G; Manetti L; Raffaelli V; Sardella C; Martino E; Bogazzi F
    Horm Metab Res; 2014 Dec; 46(13):939-42. PubMed ID: 25230324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pregnancy: a way of recovering from prolactin-secreting adenoma? 18 cases].
    Bricaire C; Kerlan V; Kuttenn F; Mauvais-Jarvis P
    Presse Med; 1988 Nov; 17(40):2117-9. PubMed ID: 2974140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
    Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
    J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apropos of the article by Ph. Otten et al.: " Pituitary adenomas secreting prolactin"].
    Perrin G
    Neurochirurgie; 1996; 42(4-5):249-50. PubMed ID: 9084752
    [No Abstract]   [Full Text] [Related]  

  • 14. Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors.
    Raverot G; Vasiljevic A; Jouanneau E; Lasolle H
    Eur J Endocrinol; 2019 Aug; 181(2):C1-C3. PubMed ID: 31167164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of prolactin-secreting pituitary adenomas.
    Neal JH; Weiss MH
    West J Med; 1990 Nov; 153(5):546-7. PubMed ID: 2260295
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcome of multimodal therapy for giant prolactinomas.
    Andujar-Plata P; Villar-Taibo R; Ballesteros-Pomar MD; Vidal-Casariego A; Pérez-Corral B; Cabezas-Agrícola JM; Álvarez-Vázquez P; Serramito R; Bernabeu I
    Endocrine; 2017 Jan; 55(1):231-238. PubMed ID: 27704480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin-secreting tumors: what's new?
    Molitch ME
    Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S29-35. PubMed ID: 17004854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
    Smith MV; Laws ER
    Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments of multi-invasive giant prolactinoma.
    Yang MY; Shen CC; Ho WL
    J Clin Neurosci; 2004 Jan; 11(1):70-5. PubMed ID: 14642373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 25-hydroxyvitamin D Correlation with Prolactin Levels and Adenoma Size in Female Patients with Newly Diagnosed Prolactin Secreting Adenoma.
    Aboelnaga MM; Abdullah N; El Shaer M
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):219-225. PubMed ID: 28595559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.